Cargando…

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

OBJECTIVE: This study evaluates the utility of urinary pro-thrombotic molecules such as tissue factor (TF), anti-thrombotic molecules such as tissue factor pathway inhibitor (TFPI), and fibrinolytic molecules such as plasmin and d-dimer as biomarkers of lupus nephritis (LN). METHODS: Urine samples f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Ling, Stanley, Samantha, Ding, Huihua, Zhang, Ting, Truong, Van, Celhar, Teja, Fairhurst, Anna-Marie, Pedroza, Claudia, Petri, Michelle, Saxena, Ramesh, Mohan, Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637532/ https://www.ncbi.nlm.nih.gov/pubmed/31319876 http://dx.doi.org/10.1186/s13075-019-1959-y

Ejemplares similares

Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

The spectrum of renal thrombotic microangiopathy in lupus nephritis
por: Song, Di, et al.
Publicado: (2013)

Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
por: Stanley, Samantha, et al.
Publicado: (2020)

Comprehensive Urinomic Identification of Protein Alternatives to Creatinine Normalization for Diagnostic Assessment of Lupus Nephritis
por: Soomro, Sanam, et al.
Publicado: (2022)

Author Correction: Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
por: Stanley, Samantha, et al.
Publicado: (2020)

Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis
por: Massicotte-Azarniouch, David, et al.
Publicado: (2022)

Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment
por: Celhar, Teja, et al.
Publicado: (2014)

Modelling clinical systemic lupus erythematosus: similarities, differences and success stories
por: Celhar, Teja, et al.
Publicado: (2017)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis
por: Pattanashetti, N., et al.
Publicado: (2017)

Low‐Density Neutrophils in Systemic Lupus Erythematosus
por: Tay, Sen Hee, et al.
Publicado: (2020)

Two Types of Renovascular Lesions in Lupus Nephritis with Clinical Thrombotic Thrombocytopenic Purpura
por: Sekine, Akinari, et al.
Publicado: (2015)

Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis
por: Tseng, Min-Hua, et al.
Publicado: (2021)

Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications
por: Sharma, Chhavi, et al.
Publicado: (2021)

Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
por: Torres, Everardo Arias, et al.
Publicado: (2021)

Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology
por: Ding, Huihua, et al.
Publicado: (2020)

Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients
por: Marchetti, Marina, et al.
Publicado: (2022)

Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study
por: Li, Qiu-Yu, et al.
Publicado: (2016)

Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation
por: Zhang, Binshan, et al.
Publicado: (2022)

Pathways leading to an immunological disease: systemic lupus erythematosus
por: Zharkova, Olga, et al.
Publicado: (2017)

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
por: Chalmers, Samantha A., et al.
Publicado: (2022)

Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis
por: Wu, Tianfu, et al.
Publicado: (2016)

Deep vein thrombosis as thrombotic sequelae of vaccine-induced thrombotic thrombocytopenia
por: Osei, Racheal, et al.
Publicado: (2023)

Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages
por: Zhang, Ting, et al.
Publicado: (2020)

Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

Urinary Tract Infection Associated With Thrombotic Microangiopathy
por: Ardalan, Mohammadreza
Publicado: (2014)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome
por: Ono, Masafumi, et al.
Publicado: (2018)

Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
por: Mok, Chi Chiu, et al.
Publicado: (2018)

Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

Urine proteomic insights from the belimumab in lupus nephritis trial
por: Weeding, Emma, et al.
Publicado: (2022)

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019)

Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer
por: Anderson, Ronald, et al.
Publicado: (2023)

A Systematic Review of Interpathologist Agreement in Histologic Classification of Lupus Nephritis
por: Dasari, Shobha, et al.
Publicado: (2019)

Discovery of Novel Circulating Immune Complexes in Lupus Nephritis Using Immunoproteomics
por: Tang, Chenling, et al.
Publicado: (2022)

Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
por: Soliman, Samar A., et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012)

Thrombotic thrombocytopenic purpura as the first presentation in systemic lupus erythematosus
por: Bamidele, Opeyemi Folorunsho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_40o86ou08l50vgrgd2huqud2nj